- Home
- IMNM vs MOMO Comparison
IMNM vs MOMO Comparison
Compare IMNM & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- MOMO
- Stock Information
- Founded
- IMNM 2006
- MOMO 2011
- Country
- IMNM United States
- MOMO China
- Employees
- IMNM N/A
- MOMO N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- MOMO Computer Software: Prepackaged Software
- Sector
- IMNM Health Care
- MOMO Technology
- Exchange
- IMNM Nasdaq
- MOMO Nasdaq
- Market Cap
- IMNM 945.8M
- MOMO 909.4M
- IPO Year
- IMNM 2020
- MOMO 2014
- Fundamental
- Price
- IMNM $10.60
- MOMO $8.23
- Analyst Decision
- IMNM Strong Buy
- MOMO Buy
- Analyst Count
- IMNM 5
- MOMO 2
- Target Price
- IMNM $26.40
- MOMO $10.00
- AVG Volume (30 Days)
- IMNM 965.4K
- MOMO 1.1M
- Earning Date
- IMNM 08-11-2025
- MOMO 09-02-2025
- Dividend Yield
- IMNM N/A
- MOMO 3.59%
- EPS Growth
- IMNM N/A
- MOMO N/A
- EPS
- IMNM N/A
- MOMO 1.06
- Revenue
- IMNM $10,938,000.00
- MOMO $1,450,201,337.00
- Revenue This Year
- IMNM N/A
- MOMO $1.04
- Revenue Next Year
- IMNM $259.34
- MOMO $3.62
- P/E Ratio
- IMNM N/A
- MOMO $7.97
- Revenue Growth
- IMNM N/A
- MOMO N/A
- 52 Week Low
- IMNM $5.15
- MOMO $5.12
- 52 Week High
- IMNM $16.81
- MOMO $9.22
- Technical
- Relative Strength Index (RSI)
- IMNM 60.20
- MOMO 45.59
- Support Level
- IMNM $10.33
- MOMO $8.38
- Resistance Level
- IMNM $11.08
- MOMO $8.56
- Average True Range (ATR)
- IMNM 0.60
- MOMO 0.22
- MACD
- IMNM 0.04
- MOMO -0.12
- Stochastic Oscillator
- IMNM 72.31
- MOMO 5.10
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.